BG1805 Injection

· Guangzhou Bio-gene Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BG1805 Injection, covering 2025-04-17 to 2025-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]

See pricing